Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions

Details for Australian Patent Application No. 2008343842 (hide)

Owner CoDa Therapeutics, Inc.

Inventors Duft, Bradford J.

Agent Spruson & Ferguson

Pub. Number AU-A-2008343842

PCT Pub. Number WO2009/085271

Priority 61/008,834 21.12.07 US

Filing date 22 December 2008

Wipo publication date 9 July 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 41/00 (2006.01) Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/085271 Priority application(s): WO2009/085271

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008343843-Improved medical devices

2008343841-Use of inhibitors of connexin43 for treatment of fibrotic conditions